Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Combination of HIF-1α gene transfection and HIF-1-activated bone marrow-derived angiogenic cell infusion improves burn wound healing in aged mice

Abstract

Impaired burn wound healing in the elderly represents a major clinical problem. Hypoxia-inducible factor-1 (HIF-1) is a transcriptional activator that orchestrates the cellular response to hypoxia. Its actions in dermal wounds promote angiogenesis and improve healing. In a murine burn wound model, aged mice had impaired wound healing associated with reduced levels of HIF-1. When gene therapy with HIF-1 alone did not correct these deficits, we explored the potential benefit of HIF-1 gene therapy combined with the intravenous infusion of bone marrow-derived angiogenic cells (BMDACs) cultured with dimethyloxalylglycine (DMOG). DMOG is known to reduce oxidative degradation of HIF-1. The mice treated with a plasmid DNA construct expressing a stabilized mutant form of HIF-1α (CA5-HIF-1α)+BMDACs had more rapid wound closure. By day 17, there were more mice with completely closed wounds in the treated group (χ2, P=0.05). The dermal blood flow measured by laser Doppler showed significantly increased wound perfusion on day 11. Homing of BMDACs to the burn wound was dramatically enhanced by CA5-HIF-1α gene therapy. HIF-1α mRNA expression in the burn wound was increased after transfection with CA5-HIF-1α plasmid. Our findings offer insight into the pathophysiology of burns in the elderly and point to potential targets for developing new therapeutic strategies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

Marc G. Jeschke, Margriet E. van Baar, … Sarvesh Logsetty

References

  1. Xing D, Liu L, Marti GP, Zhang X, Reinblatt M, Milner SM et al. Hypoxia and hypoxia-inducible factor in the burn wound. Wound Repair Regen 2011; 19: 205–213.

    Article  Google Scholar 

  2. Semenza GL . Hypoxia-inducible factors in physiology and medicine. Cell 2012; 148: 399–408.

    Article  CAS  Google Scholar 

  3. Frenkel-Denkberg G, Gershon D, Levy AP . The function of hypoxia-inducible factor 1 (HIF-1) is impaired in senescent mice. FEBS Lett 1999; 462: 341–344.

    Article  CAS  Google Scholar 

  4. Rivard A, Berthou-Soulie L, Principe N, Kearney M, Curry C, Branellec D et al. Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J Biol Chem 2000; 275: 29643–29647.

    Article  CAS  Google Scholar 

  5. Chang EI, Loh SA, Ceradini DJ, Chang EI, Lin SE, Bastidas N et al. Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1alpha stabilization during ischemia. Circulation 2007; 116: 2818–2829.

    Article  CAS  Google Scholar 

  6. Zhang X, Sarkar K, Rey S, Sebastian R, Andrikopoulou E, Marti GP et al. Aging impairs the mobilization and homing of bone marrow-derived angiogenic cells to burn wounds. J Mol Med (Berl) 2011; 89: 985–995.

    Article  CAS  Google Scholar 

  7. Bosch-Marce M, Okuyama H, Wesley JB, Sarkar K, Kimura H, Liu YV et al. Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion following limb ischemia. Circ Res 2007; 101: 1310–1318.

    Article  CAS  Google Scholar 

  8. Loh SA, Chang EI, Galvez MG, Thangarajah H, El-ftesi S, Vial IN et al. SDF-1 alpha expression during wound healing in the aged is HIF dependent. Plast Reconstr Surg 2009; 123: 65S–75S.

    Article  CAS  Google Scholar 

  9. Liu L, Marti GP, Wei X, Zhang X, Zhang H, Liu YV et al. Age-dependent impairment of HIF-1alpha expression in diabetic mice: correction with electroporation-facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells. J Cell Physiol 2008; 217: 319–327.

    Article  CAS  Google Scholar 

  10. Zhang X, Liu L, Wei X, Tan YS, Tong L, Chang R et al. Impaired angiogenesis and mobilization of circulating angiogenic cells in HIF-1alpha heterozygous-null mice after burn wounding. Wound Repair Regen 2010; 18: 193–201.

    Article  CAS  Google Scholar 

  11. Sarkar K, Rey S, Zhang X, Sebastian R, Marti GP, Fox-Talbot K et al. Tie2-dependent knockout of HIF-1 impairs burn wound vascularization and homing of bone marrow-derived angiogenic cells. Cardiovasc Res 2012; 93: 162–169.

    Article  CAS  Google Scholar 

  12. Andrikopoulou E, Zhang X, Sebastian R, Marti G, Liu L, Milner SM et al. Current insights into the role of HIF-1 in cutaneous wound healing. Curr Mol Med 2011; 11: 218–235.

    Article  CAS  Google Scholar 

  13. Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, Berg-Dixon S et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 2003; 93: 1074–1081.

    Article  CAS  Google Scholar 

  14. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007; 109: 1801–1809.

    Article  CAS  Google Scholar 

  15. Horrevoets AJ . Angiogenic monocytes: another colorful blow to endothelial progenitors. Am J Pathol 2009; 174: 1594–1596.

    Article  CAS  Google Scholar 

  16. Morris LM, Klanke CA, Lang SA, Pokall S, Maldonado AR, Vuletin JF et al. Characterization of endothelial progenitor cells mobilization following cutaneous wounding. Wound Repair Regen 2010; 18: 383–390.

    Article  Google Scholar 

  17. Elvidge GP, Glenny L, Appelhoff RJ, Ratcliffe PJ, Ragoussis J, Gleadle JM . Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways. J Biol Chem 2006; 281: 15215–15226.

    Article  CAS  Google Scholar 

  18. Rey S, Lee K, Wang CJ, Gupta K, Chen S, McMillan A et al. Synergistic effect of HIF-1alpha gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia. Proc Natl Acad Sci USA 2009; 106: 20399–20404.

    Article  CAS  Google Scholar 

  19. Rey S, Luo W, Shimoda LA, Semenza GL . Metabolic reprogramming by HIF-1 promotes the survival of bone marrow-derived angiogenic cells in ischemic tissue. Blood 2011; 117: 4988–4998.

    Article  CAS  Google Scholar 

  20. Sarkar K, Fox-Talbot K, Steenbergen C, Bosch-Marce M, Semenza GL . Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice. Proc Natl Acad Sci USA 2009; 106: 18769–18774.

    Article  CAS  Google Scholar 

  21. Chen JS, Wong VW, Gurtner GC . Therapeutic potential of bone marrow-derived mesenchymal stem cells for cutaneous wound healing. Front Immunol 2012; 3: 192.

    Article  Google Scholar 

  22. Zhang X, Wei X, Liu L, Marti GP, Ghanamah MS, Arshad MJ et al. Association of increasing burn severity in mice with delayed mobilization of circulating angiogenic cells. Arch Surg 2010; 145: 259–266.

    Article  Google Scholar 

Download references

Acknowledgements

Funding for this work was provided by a subcontract to Johns Hopkins University from the NIH STTR of Canton Biotechnologies Inc., Baltimore, MD, R01 GM093023, as well as by funding from the Hendrix Burn Fund of Johns Hopkins University. This work was partly funded by the Science and Technology Project of Shaanxi Province, PR China.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J W Harmon.

Ethics declarations

Competing interests

Drs John W Harmon and Guy P Marti report conflict of interest with equity in Canton Biotechnologies Inc., a startup biotech company formed to develop wound-healing technologies for clinical use. The remaining authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Du, J., Liu, L., Lay, F. et al. Combination of HIF-1α gene transfection and HIF-1-activated bone marrow-derived angiogenic cell infusion improves burn wound healing in aged mice. Gene Ther 20, 1070–1076 (2013). https://doi.org/10.1038/gt.2013.32

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2013.32

Keywords

This article is cited by

Search

Quick links